AVAYL was founded in 2023 and uses artificial intelligence to help pharmaceutical and life science companies identify the most effective optimization opportunities within complex and established product portfolios. The company’s technology analyzes large volumes of portfolio and operational data to uncover strategies that improve efficiency, profitability, and decision-making. By applying AI-driven insights to portfolio management and optimization, AVAYL supports pharma and life science organizations in making more informed and data-driven business decisions.